PMID: 9164707Mar 1, 1997Paper

Omega-3 fatty acids in the prevention-management of cardiovascular disease

Canadian Journal of Physiology and Pharmacology
A P Simopoulos

Abstract

Epidemiologic studies show that populations who eat fish versus those who do not have a reduced death rate from cardiovascular disease. Experimental studies have shown that omega-3 fatty acids affect the function of cells involved in atherothrombosis in numerous ways, including the modification of eicosanoid products in the cyclooxygenase and lipoxygenase pathways, the reduced synthesis of cytokines and platelet-derived growth factor, and alterations of leukocyte and endothelial cell properties. Intervention studies in patients with restenosis, myocardial infarction, and cardiac arrhythmias with omega-3 fatty acid supplementation have been addressed in several clinical studies. The ingestion of omega-3 fatty acids following one episode of myocardial infarction appears to decrease the rate of cardiac death. These effects of omega-3 fatty acids appear to be due to their antiarrhythmic properties. In fact, fish oil has been shown to reduce ventricular arrhythmias and to be more beneficial than currently used pharmacologic agents. The dose, duration, and mechanisms involved in the prevention and management of cardiovascular disease following omega-3 fatty acid ingestion or supplementation need to be investigated by double blind con...Continue Reading

References

Apr 1, 1992·Circulation·R I Ogilvie, D Zborowska-Sluis
Jun 1, 1992·American Heart Journal·P L McLennanJ S Charnock
May 9, 1985·The New England Journal of Medicine·D KromhoutC de Lezenne Coulander
May 9, 1985·The New England Journal of Medicine·B E PhillipsonD R Illingworth
Nov 1, 1984·Metabolism: Clinical and Experimental·W S HarrisD R Illingworth
Jul 1, 1984·The Journal of Clinical Investigation·P J NestelR Boston
Nov 1, 1995·The American Journal of Cardiology·A SellmayerP C Weber
Nov 1, 1995·JAMA : the Journal of the American Medical Association·D S SiscovickL H Kushi
Apr 1, 1995·International Journal of Epidemiology·D KromhoutC H Bowles
Apr 13, 1995·The New England Journal of Medicine·A AscherioW C Willett
Nov 1, 1994·Circulation·A LeafA E Raizner
Jan 1, 1996·The American Journal of Cardiology·J EritslandM Abdelnoor

❮ Previous
Next ❯

Citations

Mar 28, 2002·Pharmacology & Therapeutics·S M GarasN A Scott
Nov 13, 2010·Circulation Research·Matthew Spite, Charles N Serhan
Jan 1, 2002·Environmental Health and Preventive Medicine·Artemis P Simopoulos
Nov 5, 2003·International Journal of Circumpolar Health·Nancy K McGrath-HannaAbel Bult-Ito

❮ Previous
Next ❯

Related Concepts

Related Feeds

Atrial Fibrillation

Atrial fibrillation is a common arrhythmia that is associated with substantial morbidity and mortality, particularly due to stroke and thromboembolism. Here is the latest research.

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.

Anti-Arrhythmic Drug Therapies

Anti-arrhythmic drugs are used to prevent abnormal heart rhythms. These medications are used in conditions including, ventricular tachycardia, ventricular fibrillation and atrial fibrillation. Discover the latest research on anti-arrhythmic drug therapies here.

Antiarrhythmic Agents: Mechanisms of Action

Understanding the mechanism of action of antiarrhythmic agents is essential in developing new medications as treatment of cardiac arrhythmias is currently limited by the reduced availability of safe and effective drugs. Discover the latest research on Antiarrhythmic Agents: Mechanism of Action here.